Thanks Phaedrus - the stats are very instructive in potentially demonstrating the regulator’s blind spot. It’s an interesting angle.
Perhaps the numbers could be reproduced and framed in terms of a question to Dr. Klinker. I noticed a while back that he went straight from interning at the FDA while doing his PhD to a permanent role - yes he may have a lot of research experience, but if you pop that question and steer him towards a reality check, he might look at the numbers staring at him and start thinking about what institutional bias there might be. (I say that because I have the same worry about my son who’s gone straight from
fininishing his PhD to a pure research job.) The answer could be as simple or mundane as their adoption of the popular contempt towards a dodgy stem cell industry that has escaped regulatory scrutiny for a very long time. Sometimes it’s just useful to be able to look at things with different lenses.
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
Cell Therapy News/Articles, page-17542
-
-
- There are more pages in this discussion • 241 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
99.0¢ |
Change
-0.035(3.41%) |
Mkt cap ! $1.130B |
Open | High | Low | Value | Volume |
$1.03 | $1.04 | 96.5¢ | $8.837M | 8.885M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 59782 | 99.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
99.5¢ | 26617 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 59782 | 0.990 |
1 | 10000 | 0.980 |
1 | 20000 | 0.975 |
19 | 191088 | 0.970 |
5 | 91150 | 0.965 |
Price($) | Vol. | No. |
---|---|---|
0.995 | 26617 | 2 |
1.000 | 127185 | 8 |
1.005 | 61027 | 3 |
1.010 | 5000 | 2 |
1.015 | 7142 | 3 |
Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |